[Long-term rituximab treatment of refractory idiopathic inflammatory myopathy: A report of 3 cases].

Yi, W X; Wei, C J; Wu, Y; Bao, X H; Xiong, H; Chang, X Z

Yi, W X; Wei, C J; Wu, Y; Bao, X H; Xiong, H; Chang, X Z.

Afiliação

Yi WX; Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Wei CJ; Department of Pediatrics, Cangzhou Central Hospital, Cangzhou 061000, Hebei, China.
Wu Y; Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Bao XH; Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Xiong H; Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Chang XZ; Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.

Beijing Da Xue Xue Bao Yi Xue Ban ; 53(6): 1191-1195, 2021 Dec 18.

Article em Zh | MEDLINE | ID: mdl-34916704

Assuntos

Imageamento por Ressonância Magnética; Miosite; Criança; Feminino; Glucocorticoides; Humanos; Lactente; Miosite/tratamento farmacológico; Rituximab

Palavras-chave

Idiopathic inflammatory myopathy; Myositis specific antibodies; Refractory; Rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imageamento por Ressonância Magnética / Miosite Tipo de estudo: Prognostic_studies Limite: Child / Female / Humans / Infant Idioma: Zh Revista: Beijing Da Xue Xue Bao Yi Xue Ban Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google